Identification and Management of Alcohol Withdrawal Syndrome

2015/02/09 by Antonio Mirijello, Cristina D’Angelo, Anna Ferrulli +6 · 27 citations
Medicine · #Alcoholism and Thiamine Deficiency #Neurological and metabolic disorders #Electroconvulsive Therapy Studies

paper · doi:10.1007/s40265-015-0358-1

Cited by

• Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment.
• Assessment of agitation and aggression in inpatients with alcohol use disorder: A systematic review of informant‐based scales
• Gabapentin potentiates sensitivity to the interoceptive effects of alcohol and increases alcohol self-administration in rats. [europepmc]
• Management of Alcohol Use Disorder in Patients Requiring Liver Transplant. [europepmc]
• A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder. [europepmc]
• Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review. [europepmc]
• Noradrenergic targets for the treatment of alcohol use disorder. [europepmc]
• From gene networks to drugs: systems pharmacology approaches for AUD. [europepmc]
• Abstinence and low risk drinking during treatment: Association with psychosocial functioning, alcohol use, and alcohol problems 3 years following treatment. [europepmc]
• Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?: The Rational Clinical Examination Systematic Review. [europepmc]
• Baclofen for the Treatment of Alcohol Use Disorder in Patients With Liver Cirrhosis: 10 Years After the First Evidence. [europepmc]
• Alcohol consumption analysis among patients with liver disease in China. [europepmc]
• Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia. [europepmc]
• Advances in the science and treatment of alcohol use disorder. [europepmc]
• Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows. [europepmc]
• Actigraphy assessment of motor activity and sleep in patients with alcohol withdrawal syndrome and the effects of intranasal oxytocin. [europepmc]
• Management of Alcohol Withdrawal in the Emergency Department: Current Perspectives. [europepmc]
• Alcohol Use Disorder, Neurodegeneration, Alzheimer's and Parkinson's Disease: Interplay Between Oxidative Stress, Neuroimmune Response and Excitotoxicity. [europepmc]
• The effect of alcohol withdrawal syndrome severity on sleep, brain and cognition. [europepmc]
• Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents. [europepmc]
• Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. [europepmc]
• Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder. [europepmc]
• Alcohol withdrawal syndrome in ICU patients: Clinical features, management, and outcome predictors. [europepmc]
• Behavioral characterization of withdrawal following chronic voluntary ethanol consumption via intermittent two-bottle choice points to different susceptibility categories. [europepmc]
• The Amygdala Noradrenergic System Is Compromised With Alcohol Use Disorder. [europepmc]
• Clinical Impact of the CYP2C19 Gene on Diazepam for the Management of Alcohol Withdrawal Syndrome. [europepmc]
• Alcohol-Associated Liver Disease: Evolving Concepts and Treatments. [europepmc]